FDA’s warning on Rheumatoid Arthritis drug Arava: What next?
FDA's warning on Arava (Leflunomide): Risk of severe liver injury
What is a patient or doctor to do? (yes, we said patient, and not only the doctors, because it is your body…)
So MediNewsDigest has located a site where comparisons beyween similar drugs are made:
Comparison of Arava (Leflunomide) with other RA drugs (drugdigest): Well, the drugs are not that easy to compare and, as always, a discussion with your doctor is necessary. Might involve trial and error, or whichever he knows best.
Categories: Alert, Drug Safety, Drugs and Devices, Rheumatoid Arthritis, Safety and Side Effects, autoimmune diseases Tags: Arava, CareResourceGuide, drugdigest, FDA, Leflunomide, medinewsdigest, RA, Rheumatoid Arthritis
Pain/RA: Associations between weather factors and severity of pain in rheumatoid arthritis (MDLinx)
MediNewsDigest:
Some association acknowledged, but you already knew that….
Categories: Arthritis, Chronic Pain, Rheumatoid Arthritis, pain Tags: Arthritis, CareResourceGuide, mdlinx, medinewsdigest, pain, RA, rain, weather
Rheumatoid Arthritis and Diet (WebMD)
MediNewsDigest: Discussion on Omega’s 6 vs.3 is particularly interesting
Categories: Inflammation, Nutrition, Rheumatoid Arthritis, pain Tags: CareResourceGuide, diet, medinewsdigest, RA, Rheumatoid Arthritis, WebMD
Categories: Alert, Drug Safety, Rheumatoid Arthritis, autoimmune diseases, psoriasis Tags: CareResourceGuide, Efalizumab, Inflammatory Polyarthritis, PML, RA, sjcrg
Rheumatoid Arthritis Actemra will steal shares in RA Market (Majestic)
SJCRG: An interesting discussion on RA Pharma from the point of view of business.
Categories: Arthritis, Rheumatoid Arthritis, autoimmune diseases Tags: Actemra, CareResourceGuide, Majestic, Market, RA, Rheumatoid Arthritis, shares, sjcrg, steal
